Technical Implications And Cost Considerations Of BioProcess Automation
Just how much time and capital does it take to implement process automation in a biopharma environment? I this segment of the BioProcess Online Live event _BioProcess Automation: Truth Or Illusion, we get hot takes on those topics from iBio COO Randy Maddux, Sutro Bio VP of Manufacturing & Plant Operations Devendra Luhar, and Kyowa Kirin EVP of Operations and Supply Chain Paul Testa.
VIEW THE VIDEO! Log In
Get unlimited access to:
Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X
Enter your credentials below to log in. Not yet a member of Biosimilar Development? Subscribe today.
Subscribe to Biosimilar Development X
Subscribe to Biosimilar Development